Vertex Pharmaceuticals Incorporated
About Vertex
Vertex Pharmaceuticals Incorporated is a biotechnology company focused on developing and commercializing therapies for serious diseases, with a core focus on cystic fibrosis (CF).
-
Cystic Fibrosis: TRIKAFTA (for CF patients aged 6+ with at least one F508del mutation), SYMDEKO/SYMKEVI, ORKAMBI, KALYDECO (target specific CFTR gene mutations)
-
Pipeline Therapies:
-
AAT Deficiency: VX-864 (Phase 2)
-
Kidney Diseases: VX-147 for APOL1-mediated FSGS and related kidney conditions (Phase 2)
-
Type 1 Diabetes: VX-880 (Phase 1/2)
-
Pain Management: VX-548, a NaV1.8 inhibitor for acute, neuropathic, and musculoskeletal pain (Phase 2)
-
Sickle Cell Disease and Beta-Thalassemia: CTX001 (Phase 3, in collaboration with CRISPR Therapeutics)
-
The company primarily sells its products to specialty pharmacies and distributors in the U.S., and to hospitals, clinics, and retail chains internationally.
Collaborations: Vertex partners with Affinia Therapeutics, Arbor Biotechnologies, CRISPR Therapeutics, Kymera Therapeutics, Mammoth Biosciences, Moderna, Obsidian Therapeutics, Skyhawk Therapeutics, Ribometrix, Genomics plc, Merck KGaA, and X-Chem.
Vertex was founded in 1989 and is headquartered in Boston, Massachusetts.
Vertex's Business Strategy
Vertex operates with a focused innovation strategy, specializing in developing transformative medicines for serious diseases with significant unmet needs. The company has established market dominance in cystic fibrosis (CF) through a series of increasingly effective CFTR modulator therapies that address the underlying cause of the…
Available on Finplify
Free account required
Our Take on Vertex
Pros:
✅ Leader in Cystic Fibrosis (CF): Vertex has dominant global market share in CF treatment, with its portfolio of CFTR modulators (including Trikafta/Kaftrio) addressing the vast majority of CF patients. Vertex’s CF treatments are highly effective, used long-term by patients, and face little competition,…
Available on Finplify
Free account required
Company Details
Key Metrics
Fundamental Analysis
Proprietary 5-category scoring system
Score Fingerprint
Section Scores
Full Breakdown & Peer Ranking
See the detailed score for every metric and how this stock ranks against its sector peers
Unlock the full research on Vertex
Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.
300+ Curated Stocks
A hand-picked universe of world-class businesses across every major market and sector.
AI Analyst Briefings
Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.
Proprietary Fundamentals
Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.